Skip to content

To study the Effect Of Ayurveda Panchakarma Procedures And Oral Medication in managment of Tamaka Shvasa(Bronchial Asthma)

A Comparative Clinical Study On The Effect Of Vamana Karma,Virechana Karma, Followed By Vyaghri Haritaki Rasayana in the managment of Tamaka Shavasa w.s.r. to bronchial Asthma.

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011787
Enrollment
30
Registered
2018-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diagnosed case of Shavasa (Bronchial Asthma)

Interventions

Intervention1: In this group,patients will be administered classical Vamana Karma(therapeutic emesis) followed by oral administration of Vyaghri Haritaki Rasayana: In this group,patients will be admin

Sponsors

National institute of Ayurveda
Lead Sponsor
Dr Gopesh Mangal
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1) Diagnosed case of Tamaka Shavasa/Bronchial Asthma 2) Patients fit for Vamana Karma 3) Patients fit for Virechana Karma

Exclusion criteria

Exclusion criteria: 1) Patients suffering with tuberculosis(Pulmonary )and other ,Chronic Obstructive Pulmonary Disease, like Emphysema, Pleural effusion, Status Asthmamaticus 2) Patients suffering from systematic disorders like renal failure, Hypertension, Diabetics Mellitus ,Cardiac diseases etc 3) Pregnancy 4) Patient with evidence of Maligency 5) History of hypersensitivity to trial drug or any of the ingredients

Design outcomes

Primary

MeasureTime frame
Patients of both sexes between age group 16 to 60 years diagnosed as Tamaka Shavasa (Bronchial Asthma)will be selected for relieving sing and symptoms.Timepoint: 80

Secondary

MeasureTime frame
Assess comparative efficacy of Vamana Karma and Virechana Karma along with Vyaghri Haritiki Rasayan in diagnosed case of Tamaka Shvasa(Bronchial Asthma)Timepoint: 80

Countries

India

Contacts

Public ContactAmrita Bhattarai

National Institute Of Ayurveda

gmangal108@gmail.com8619849011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026